选择语言
免费注册积分兑换
关注公众号
我的购物车
收藏产品

Human LYPD3 / C4.4A Protein, His Tag

COAMS
DS
用户评价
货号-规格
价格
Qty.
合计0件 产品金额0
0
加入购物车
新品建议
增项建议

产品详情

  • 分子别名（Synonym）

    LYPD3,MIG-C4,C4.4A

  • 表达区间及表达系统（Source）

    Human LYPD3, His Tag (LY3-H52H5) is expressed from human 293 cells (HEK293). It contains AA Leu 31 - His 286 (Accession # AAH39167).

    Predicted N-terminus: Leu 31

    Request for sequence

  • 蛋白结构（Molecular Characterization）

    LYPD3 Structure

    This protein carries a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 28.7 kDa. The protein migrates as 45-66 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • 偶联（Conjugate）

    Unconjugated

  • 内毒素（Endotoxin）

    Less than 1.0 EU per μg by the LAL method.

  • 纯度（Purity）

    95% as determined by SDS-PAGE.

  • 制剂（Formulation）

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • 重构方法（Reconstitution）

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • 存储（Storage）

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.

  • 质量管理控制体系（QMS）

    1. 质量管理体系（ISO, GMP）
    2. 质量优势
    3. 质控流程

产品展示

  • 电泳（SDS-PAGE）

    LYPD3 SDS-PAGE

    Human LYPD3, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

  • 活性（Bioactivity）-ELISA

    LYPD3 ELISA

    Immobilized Human LYPD3, His Tag (Cat. No. LY3-H52H5) at 1 μg/mL (100 μL/well) can bind various dilution ratio of Anti-LYPD3 Antibody (Rabbit Mab) (QC tested).

    Protocol

用户评价
发表评论

背景介绍

Ly6/PLAUR domain-containing protein 3 (LYPD3) is also known as MIG-C4 ,C4.4A, GPI-anchored metastasis-associated protein C4.4A homolog and Matrigel-induced gene C4 protein,which is a cell membrane protein containing two UPAR/Ly6 domains. LYPD3 is expressed in placenta, skin and urothelium. LYPD3 is found in the majority of primary and metastatic transitional cell carcinomas (TCCs) and as well in breast cancer tissues, but not in adjacent normal tissues. LYPD3 play a role in supporting cell migration and it is not only probably involved in urothelial cell-matrix interactions, but also in tumor progression.

前沿进展

 
药物研发进展
  • 英文全称：

    Ly6/PLAUR domain-containing protein 3

  • 中文全称：

    LY6/PLAUR结构域蛋白-3

  • 种类：

  • 上市药物数量：

    0 详情

  • 临床药物数量：

    1 详情

  • 最高研发阶段：

    临床一期

联系我们
项目合作
查看更多项目
  • 产品SKU
  • 产品详情
  • 产品展示
  • 用户评价
  • 背景介绍